U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach. Geneva: World Health Organization; 2008.

Cover of Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach.

Show details

ANNEX 1DEFINITIONS OF DRUG USE ACCORDING TO THE 10TH REVISION OF THE INTERNATIONAL CLASSIFICATION OF DISEASES

F.11 Harmful use A pattern of psychoactive substance use that is causing damage to health. The damage may be physical (as in cases of hepatitis from the self-administration of injected psychoactive substances) or mental (e.g. episodes of depressive disorder secondary to heavy consumption of alcohol).

F.12 Dependence syndrome A cluster of behavioural, cognitive and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences, a higher priority given to drug use than to other activities and obligations, increased tolerance and sometimes a physical withdrawal state.

The dependence syndrome may be present for a specific psychoactive substance (e.g. tobacco, alcohol or diazepam), for a class of substances (e.g. opioid drugs) or for a wider range of pharmacologically different psychoactive substances.

  • Chronic alcoholism
  • Dipsomania
  • Drug addiction

Both of these definitions have subgroups, of which the following were included:

Mental and behavioural disorders due to use of opioids

Mental and behavioural disorders due to use of cocaine

Mental and behavioural disorders due to use of hallucinogens

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances

This category should be used when two or more psychoactive substances are known to be involved, but it is impossible to assess which substance is contributing most to the disorders. It should also be used when the exact identity of some or even all the psychoactive substances being used is uncertain or unknown, since many multiple drug users themselves often do not know the details of what they are taking.

Includes: misuse of drugs NOS [not otherwise specified]

Copyright © World Health Organization 2008.

All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: tni.ohw@snoissimrep).

Bookshelf ID: NBK321184

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.2M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...